Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AYI
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 1,000 | $325.00 | $325.0K Sale | Form 4 ↗ |
| Nov 2, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 3,000 | $323.45 | $970.4K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 282 | $325.07 | $91.7K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 238 | $323.86 | $77.1K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 920 | $323.04 | $297.2K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 388 | $321.80 | $124.9K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 772 | $320.48 | $247.4K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 800 | $319.22 | $255.4K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 2,640 | $318.54 | $840.9K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 560 | $317.32 | $177.7K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 817 | $316.02 | $258.2K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 1,040 | $315.02 | $327.6K Sale | Form 4 ↗ |
| Oct 30, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 760 | $313.98 | $238.6K Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 480 | $327.30 | $157.1K Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 1,155 | $326.29 | $376.9K Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 3,512 | $325.30 | $1.1M Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 1,320 | $324.37 | $428.2K Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 240 | $323.01 | $77.5K Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 720 | $321.84 | $231.7K Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 400 | $320.69 | $128.3K Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 120 | $318.09 | $38.2K Sale | Form 4 ↗ |
| Oct 29, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 240 | $316.28 | $75.9K Sale | Form 4 ↗ |
| Oct 28, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 280 | $320.00 | $89.6K Sale | Form 4 ↗ |
| Oct 28, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 1,948 | $318.84 | $621.1K Sale | Form 4 ↗ |
| Oct 28, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 7,295 | $318.22 | $2.3M Sale | Form 4 ↗ |
| Oct 28, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 6,544 | $317.03 | $2.1M Sale | Form 4 ↗ |
| Oct 28, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 5,286 | $316.14 | $1.7M Sale | Form 4 ↗ |
| Oct 28, 2026 | Neil Ashe President & CEO, Director | AYI Acuity Inc. | Sale | 707 | $314.53 | $222.4K Sale | Form 4 ↗ |
| Oct 27, 2026 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 3,800 | $321.48 | $1.2M Sale | Form 4 ↗ |
| Oct 16, 2026 | Laura O'Shaughnessy Director | AYI Acuity Inc. | Buy | 73 | $302.32 | $22.1K Buy | Form 4 ↗ |
| Sep 1, 2026 | Karen J. Holcom SVP & Chief Financial Officer | AYI Acuity Inc. | Sale | 2,000 | $329.62 | $659.2K Sale | Form 4 ↗ |
| Jul 2, 2026 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 1,200 | $365.65 | $438.8K Sale | Form 4 ↗ |
| Jun 1, 2026 | Karen J. Holcom SVP & Chief Financial Officer | AYI Acuity Inc. | Sale | 2,076 | $303.14 | $629.3K Sale | Form 4 ↗ |
| Apr 30, 2026 | Maya Leibman Director | AYI Acuity Inc. | Buy | 200 | $288.83 | $57.8K Buy | Form 4 ↗ |
| Apr 8, 2026 | Laura O'Shaughnessy Director | AYI Acuity Inc. | Buy | 1,000 | $282.98 | $283.0K Buy | Form 4 ↗ |
| Jan 28, 2026 | Karen J. Holcom SVP & Chief Financial Officer | AYI Acuity Inc. | Sale | 4,974 | $309.23 | $1.5M Sale | Form 4 ↗ |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 200 | $370.23 | $74.0K Sale | Form 4 ↗ |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 493 | $368.49 | $181.7K Sale | Form 4 ↗ |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 102 | $366.65 | $37.4K Sale | Form 4 ↗ |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 470 | $365.75 | $171.9K Sale | Form 4 ↗ |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 1,839 | $364.94 | $671.1K Sale | Form 4 ↗ |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 378 | $363.79 | $137.5K Sale | Form 4 ↗ |
| Oct 28, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 1,007 | $362.80 | $365.3K Sale | Form 4 ↗ |
| Oct 24, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 2,848 | $368.32 | $1.0M Sale | Form 4 ↗ |
| Oct 24, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 1,839 | $367.54 | $675.9K Sale | Form 4 ↗ |
| Jul 1, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 1,800 | $297.87 | $536.2K Sale | Form 4 ↗ |
| Jul 1, 2025 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 2,325 | $298.64 | $694.3K Sale | Form 4 ↗ |
| Jun 27, 2025 | Karen J. Holcom SVP & Chief Financial Officer | AYI Acuity Inc. | Sale | 6,000 | $301.04 | $1.8M Sale | Form 4 ↗ |
| Oct 28, 2024 | Barry R. Goldman SVP & General Counsel | AYI Acuity Inc. | Sale | 5,120 | $305.00 | $1.6M Sale | Form 4 ↗ |
49 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:26 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances